As the Clinical Director of the Pediatric Oncology Branch I oversee the pediatric oncology clinical service at the NIH Clinical Center and have budgetary responsibility for and supervise the Branch clinical fellows, nurse practitioners, and patient care coordinator. I also oversee the NCI fellowship training program in pediatric hematology/oncology, which is a joint training program with Johns Hopkins University. I supervise and mentor the 21 fellows in our Accreditation Council for Graduate Medical Education (ACGME)-accredited training program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Training Intramural Research (ZIE)
Project #
1ZIEBC010764-07
Application #
8554191
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2012
Total Cost
$5,361,900
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
El-Mallawany, N K; Geller, L; Bollard, C M et al. (2011) Long-term remission in a child with refractory EBV(+) hydroa vacciniforme-like T-cell lymphoma through sequential matched EBV(+)-related allogeneic hematopoietic SCT followed by donor-derived EBV-specific cytotoxic T-lymphocyte immunotherapy. Bone Marrow Transplant 46:759-61
Raygada, Margarita; Arthur, Diane C; Wayne, Alan S et al. (2010) Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia. Pediatr Blood Cancer 54:173-5
Jegalian, Armin G; Buxbaum, Nataliya P; Facchetti, Fabio et al. (2010) Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications. Haematologica 95:1873-9
Dunleavy, Kieron; Little, Richard F; Pittaluga, Stefania et al. (2010) The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood 115:3017-24
Porter, David L; Alyea, Edwin P; Antin, Joseph H et al. (2010) NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 16:1467-503
Wayne, Alan S; Capitini, Christian M; Mackall, Crystal L (2010) Immunotherapy of childhood cancer: from biologic understanding to clinical application. Curr Opin Pediatr 22:2-11
Wayne, Alan S; Baird, Kristin; Egeler, R Maarten (2010) Hematopoietic stem cell transplantation for leukemia. Pediatr Clin North Am 57:1-25
Kroger, Nicolaus; Bacher, Ulrike; Bader, Peter et al. (2010) NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogenei Biol Blood Marrow Transplant 16:1325-46
Wayne, Alan S; Kreitman, Robert J; Findley, Harry W et al. (2010) Anti-CD22 immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-positive hematologic malignancies of childhood: preclinical studies and phase I clinical trial. Clin Cancer Res 16:1894-903
Capitini, Christian M; Mackall, Crystal L; Wayne, Alan S (2010) Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther 10:163-78

Showing the most recent 10 out of 14 publications